Beta-amÝn¾ tetrah²dr¾imÝdas¾ (1, 2-a) p²rasÝn og tetrah²dr¾trÝas¾l¾ (4, 3-a) p²rasÝn sem dÝpeptÝd²l peptÝ-asa hindrar til me-h÷ndlunar e-a forvarnar ß sykurs²ki.

摘要

The present invention is directed to pharmaceutical compositions comprising compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and the use of these compositions in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes.